Strategic T Cells Use May Be the Key to Effective Cancer Treatment
Results showed that the two types of cells are controlled by completely different wiring. In a separate study, use of checkpoint inhibitors gave the exhausted T cells a temporary boost, but did nothing to convert them to an active state.
The researchers hope this information will help to improve CAR T-cell therapy, in which T cells are removed from a patient and retrofitted to attack tumor cells. Complete mapping of regulatory regions will provide more precise targets for treatment.
New Liquid Biopsy Finds Cancer Markers Even Before Illness for Early Action
Pathway Genomics, a global health and research company, has developed a liquid biopsy test which can detect cancerous mutant DNA in completely healthy people. A liquid biopsy is an examination of fluid or blood drawn from the individual to find cancer cells within the blood.
The test utilizes gene sequencing to compare genetic markers within the person's blood sample. Those markers are then contrasted with genetic markers found in common cancers such as ovarian, breast, lung, and colon cancers. If there are genetic markers that match, then the test has found evidence that the patient is at risk of contracting said cancer in the future.
Videos – What Do Patients Say About Their Experience?
Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.
|